Clinical Trial Update: E7070 in Treating Patients With Stage IV Melanoma [Phase 2]

View source ↗

Summary

This clinical trial update concerns a Phase 2 study of E7070 in stage IV melanoma; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• E7070

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED